SIRT3 inhibits Ang II-induced transdifferentiation of cardiac fibroblasts through β-catenin/PPAR-γ signaling
- 1 October 2017
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 186, 111-117
- https://doi.org/10.1016/j.lfs.2017.07.030
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient miceJournal of Translational Medicine, 2013
- β-Catenin Mediates Mechanically Regulated, Transforming Growth Factor-β1–Induced Myofibroblast Differentiation of Aortic Valve Interstitial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Repression of β-catenin signaling by PPARγ ligandsEuropean Journal of Pharmacology, 2010
- Modulation of PPAR-γ by telmisartan protects the heart against myocardial infarction in experimental diabetesChemico-Biological Interactions, 2010
- Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007
- A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-γ transactivationNature, 2007
- Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cells––Role of PPAR-γ in vascular fibrosisBiochemical Pharmacology, 2007
- Functional Interaction between Peroxisome Proliferator-Activated Receptor γ and β-CateninMolecular and Cellular Biology, 2006
- TGF-?1 and angiotensin networking in cardiac remodelingCardiovascular Research, 2004